中国抗体-B拟3月23日举行董事会会议以审批年度业绩

格隆汇资讯
Mar 10

格隆汇3月10日丨中国抗体-B(03681.HK)公告,谨定于2026年3月23日(星期一)举行董事会会议,以考虑及通过集团截至2025年12月31日止年度全年业绩及其发布,以及处理其他事项。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10